In vivo kinetics as a sensitive method for testing physiologically intact human recombinant apolipoprotein A-I: Comparison of three different expression systems

Clinica Chimica Acta

Volumn 268, Issue 1-2, 1997, Pages 41-60

  Schmidt, Hartmut H J ^a   Haas, Regina E ^a   Remaley, Alan ^a   Genschel, Janine ^a   Strassburg, Christian P ^a   Büttner, Carsten ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Baculovirus; CHO cells; E. coli; In vivo kinetics; Recombinant apoA I

Indexed keywords

APOLIPOPROTEIN A; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CARDIOVASCULAR DISEASE; CHO CELL; CHOLESTEROL TRANSPORT; ENZYME KINETICS; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STABILITY; RECOMBINANT DNA TECHNOLOGY;

ANIMALS; APOLIPOPROTEIN A-I; BACULOVIRIDAE; CHO CELLS; CHROMATOGRAPHY, LIQUID; CLONING, MOLECULAR; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; HUMANS; HYDROLYSIS; MALE; RABBITS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SPODOPTERA;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS; SPODOPTERA FRUGIPERDA; UNIDENTIFIED BACULOVIRUS;

EID: 0031564324     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00155-1     Document Type: Article

References (58)

1. Miller GJ, Miller NE Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet. 1:1975;16-20.
2. Rhoads G, Gulbrandsen CL, Kagan A Serum lipoproteins and coronary heart disease in a population study of Hawaii-Japanese men. N Engl J Med. 294:1976;293-295.
3. Castelli W, Doyle JT, Gordon Tet al. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation. 55:1977;767-772.
4. Glomset JA The plasma lecithin-cholesterol acyl transferase reaction. J Lipid Res. 9:1968;155-167.
5. Fielding CJ, Fielding PE Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
6. Dalton MB, Swaney JB Structural and functional domains of apolipoprotein A-I within high density lipoproteins. J Biol Chem. 268:1993;19274-19283.
7. Rothblat GH, Mahlberg FH, Johnson WJ, Phillips MC Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J Lipid Res. 33:1992;1091-1097.
8. Ramji DP, Tadros MH, Hardon EM, Cortese R The transcription factor LF-A1 interacts with a bipartite recognition sequence in the promoter regions of several liver-specific genes. Nucleic Acids Res. 19:1991;1139-1146.
9. Ladias JAA, Karathanasis SK Regulation of the apolipoprotein A-I gene by ARP-1, a novel member of the steroid receptor superfamily. Science. 251:1991;561-565.
10. Rader DJ, Gregg RE, Meng MSet al. In vivo metabolism of a mutant apolipoprotein, apoA-I, owa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res. 33:1992;755-763.
11. Deeb SS, Cheung MC, Peng Ret al. A mutation in the human apolipoprotein A-I gene. J Biol Chem. 266:1991;13654-13660.
12. Brinton EA, Eisenberg S, Breslow JL Increased apoA-I and apoA-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest. 87:1991;536-544.
13. Le NA, Ginsberg HN Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. Metabolism. 37:1988;614-617.
14. Morrison J, Fidge NH, Tozuka M Determination of the structural domain of apoA-I recognized by high density lipoprotein receptors. J Biol Chem. 266:1991;18780-18785.
15. Allan CM, Fidge NH, Kanellos J Antibodies to the carboxyl terminus of human apolipoprotein A-I. J Biol Chem. 267:1992;13257-13261.
16. Jonas A. Lecithin:cholesterol acyltransferase. In: Gotto AM Jr, editor. Plasma lipoproteins, new comprehensive biochemistry. Amsterdam: Elsevier Netherlands, 1987;14:314-317.
17. Fielding CJ, Shore VG, Fielding PE A protein cofactor of Lecithin:Cholesterol Acyltransferase. Biochem Biophys Res Com. 46:1972;1493-1498.
18. Banka CL, Bonnet DJ, Black AS, Smith RS, Curtiss LK Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase. J Biol Chem. 266:1991;23886-23892.
19. Meng QH, Calabresi L, Fruchart JC, Marcel YL Apolipoprotein A-I domains involved in the activation of lecithin:cholesterol acyltransferase: Importance of the central domain. J Biol Chem. 268:1993;16966-16973.
20. Sorci-Thomas M, Kearns MW, Lee JP Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation: Structure:function relationships. J Biol Chem. 268:1993;21403-21409.
21. Brewer HB Jr., Fairwell T, LaRue A, Ronan R, Houser A, Bronzert TJ The amino acid sequence of human apoA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun. 80:1978;623-630.
22. Brewer HB Jr., Fairwell T, Kay Let al. Human plasma proapoA-I: isolation and amino-terminal sequence. Biochem Biophys Res Commun. 113:1983;626-632.
23. Cheung P, Chan L Nucleotide sequence of cloned cDNA of human apolipoprotein A-I. Nucleic Acids Res. 11:1983;3703-3715.
24. Karathanasis SK, Zannis VI, Breslow JL Isolation and characterization of the human apolipoprotein A-I gene. Proc Natl Acad Sci USA. 80:1983;6147-6151.
25. Edelstein C, Gordon JI, Toscas K, Sims HF, Strauss AW, Scanu AM In vitro conversion of proapoprotein A-I to apoprotein A-I. J Biol Chem. 258:1983;11430-11433.
26. Bojanovski D, Gregg RE, Ghiselli G, Schaefer EJ, Light JA, Brewer HB Jr. Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I. J Lipid Res. 26:1985;185-193.
27. Saku K, Liu R, Ohkubo Ket al. In vivo conversion of recombinant human proapolipoprotein AI to apolipoprotein AI in rabbits. Biochim Biophys Acta. 1167:1993;257-263.
28. Beg ZH, Stonik JA, Hoeg JM, Demosky SJ, Fairwell T, Brewer HB Jr. Human apolipoprotein A-I: Post-translational modification by covalent phosphorylation. J Biol Chem. 264:1989;6913-6921.
29. Hoeg JM, Meng MS, Ronan R, Fairwell T, Brewer HB Jr. Human apolipoprotein A-I. Post-translational modification by fatty acid acylation. J Biol Chem. 261:1986;3911-3914.
30. Isacchi A, Sarmientos P, Lorenzetti R, Soria M Mature apolipoprotein A-I and its precursor proapoA-I: influence of the sequence at the 5′ end of the gene on the efficiency of expression in Escherichia coli. Gene. 81:1989;129-137.
31. Forte TM, McCall MR, Amacher S, Nordhausen RW, Vigne JL, Mallory JB Physical and chemical characteristics of apolipoprotein A-I-lipid complexes produced by chinese hamster ovary cells transfected with the human apolipoprotein A-I gene. Biochim Biophys Acta. 1047:1990;11-18.
32. Moguilewsky N, Robool C, Loriau Ret al. Production of human recombinant proapolipoprotein A-I in Escherichia coli. DNA. 8:1987;429-436.
33. Bruhn H, Stoffel W An approach to the functional analysis of lecithin:cholesterol acyltransferase: activation by recombinant normal and mutagenized apolipoprotein A-I. Biol Chem Hoppe Seyler. 372:1991;225-234.
34. Dixon JL, Battini R, Ferrari S, Redman CM, Banerjee D Expression and secretion of chicken apolipoprotein A-I in transfected COS cells. Biochim Biophys Acta. 1009:1989;47-53.
35. Moguilevsky N, Guillaume J-P, Varsalona F, Bulinckx M, Bollen A Correct in vivo processing of a chimeric ubiquitin-proapolipoprotein A-I fusion protein in bacuolvirus-infected insect cells. J Biotech. 32:1994;39-43.
36. Sorci-Thomas M, Parks JS, Kearns MW, Pate GN, Zhang C, Thomas MJ High level secretion of wild-type and mutant forms of human proapoA-I using Baculovirus-mediated Sf-9 cell expression. J Lipid Res. 37:1996;673-683.
37. McGuire KA, Davidson WS, Jonas A High yield overexpression and characterization of human recombinant proapolipoprotein A-I. J Lipid Res. 37:1996;1519-1528.
38. Pyle LE, Barton P, Fujiwara Y, Mitchell A, Fidge N Secretion of biologically active human proapolipoprotein A-I in a Baculovirus-insect cell system: protection from degradation by protease inhibitors. J Lipid Res. 36:1995;2355-2361.
39. Mallory JB, Kushner PJ, Protter AAet al. Expression and characterization of human apolipoprotein A-I in chinese hamster ovary cells. J Biol Chem. 262:1987;4241-4247.
40. Brissette L, Cahuzac-Bec N, Desforges M, Bec J-L, Marcel YL, Rassart E Expression of human recombinant apolipoprotein A-I in chinese hamster ovary cells and escherichia coli. Prot Exp Purif. 2:1991;296-303.
41. Strassburg CP, Kasai Y, Seng BAet al. Baculovirus recombinant expressing a secreted form of a transmembrane carcinoma-associated antigen. Cancer Res. 52:1992;815-821.
42. Schmidt HH-J, Remaley AT, Stonik JAet al. Carboxyl-terminal domain truncation alters apolipoprotein A-I in vivo catabolism. J Biol Chem. 270:1995;5469-5475.
43. Hames BD, Rickwood D. Gel Electrophoresis of Proteins - A Practical approach. New York: Oxford University Press NJ, 1990:101-103.
44. McFarlane AS Efficient trace-labeling of proteins with iodine. Nature. 182:1958;53.
45. Jiao S, Cole TG, Kitchens RT, Pfleger B, Schonfeld G Genetic heterogeneity of plasma lipoproteins in the mouse: control of low density lipoprotein particle sizes by genetic factors. Metabolism. 39:1990;155-160.
46. Remaley AT, Wong AW, Schumacher UK, Meng MS, Brewer HB Jr., Hoeg JM O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins. J Biol Chem. 268:1993;6785-6790.
47. Markwell MAK, Hass SM, Bieber LL, Tolbert NE A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Annal Biochem. 8:1978;206-210.
48. Wicher JT, Price CP, Spencer K Immunonephelometric and immunoturbidimetric assay for proteins. Crit Rev Clin Lab Sci. 18:1983;213-260.
49. Law SW, Brewer HB Jr. Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA. Proc Natl Acad Sci USA. 81:1984;66-70.
50. Monaco L, Lorenzetti R, Sidoli A, Soria M. Versatile E. coli expression modification vectors as tools for structure-function studies of apolipoprotein A-I. In: Human Apolipoprotein Mutants. Berlin:Springer-Verlag, 1989:153-160.
51. Kunitake ST, Chen GC, Kung SF, Schilling JW, Hardman DA, Kane JP Pre-beta high density lipoprotein. Unique disposition of apolipoprotein A-I increases susceptibility to proteolysis. Arteriosclerosis. 10:1990;25-30.
52. Osborne JC, Schaefer EJ, Powell GM, Lee NS, Zech LA Molecular properties of radioiodinated apolipoprotein A-I. J Biol Chem. 259:1984;347-353.
53. Khouw AS, Parthasarathy S, Witztum JL Radioiodination of low density lipoprotein initiates lipid peroxidation: protection by use of antioxidants. J Lipid Res. 34:1993;1483-1496.
54. Bojanovski D, Gregg RE, Zech LAet al. In vivo metabolism of proapolipoprotein A-I in Tangier Disease. J Clin Invest. 80:1987;1742-1747.
55. Ikewaki K, Rader DJ, Schaefer JR, Fairwell T, Zech LA, Brewer HB Jr. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res. 34:1993;2207-2215.
56. Fisher WR, Venkatakrshnan V, Zech LAet al. Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans. J Lipid Res. 36:1995;1618-1628.
57. Gregg RE, Zech LA, Bojanovski Det al. Tangier disease: identification of normal and rapidly catabolized forms of plasma apolipoprotein A-I. Circulation. 72(Suppl. III):1985;364.
58. Palgunachari MN, Mishra VK, Lund-Katz Set al. Only the two end helixes of eight tandem amphipathic helical domains of human apoA-I have significant lipid affinity Implications for HDL assembly. Arterioscler Thromb Vasc Biol. 16:1996;328-338.